Please note that the below speakers have consented to make their presentation public.
DAY 1
- Keynote lecture – Hilary CALVERT – ‘Challenges of innovative oncology drug development
- Paolo ASCIERTO – ‘Combining immunotherapeutic agents’
- Jun WANG – ‘Industry perspective on combination therapy in immuno-oncology’
- Jorge CAMARERO – ‘Regulatory aspects on combination therapy in immuno-oncology – EU perspective’
REPORT ON CDDF WORKING GROUPS
- ACCELERATE Platform (paediatric oncology)
- Immuno biomarker development in the peripheral blood (Vienna, December 2015)
- Use of real world data to optimise oncology drug development and access (London, July 2016)
DAY 2
- Irene BRAÑA – ‘Academic view on new trial designs’
- Heinrich RODER – ‘Prospective biomarker development’
- Alina COMANESCU – ‘Patient perspective on biomarker development and access to innovative oncology diagnostics’
DAY 3
- Karl Graham SIEGENTHALER – ‘Accelerating breakthrough molecules to breakthrough medicines’
- Belén GRACIA MONEVA – ‘Challenges in the evaluation of preclinical toxicology in immuno-oncology’
- Ignacio GARCIA-RIBAS – ‘Mind the gap: challenges in first in man evaluation of immuno oncology drugs’